A trend toward increased CYP2C19 metabolism (as determined by a lower omeprazole AUC and a higher 5′-hydroxyomeprazole/omeprazole (OH-opz/opz) AUC ratio) was noticed in five volunteers who were heterozygous carriers of CYP2C19*17 , but this did not reach statistical significance ( P = 0.06).
← all excerpts
Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.
1
0.0600
0.0600